HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$37.54
−1.08%Forward multiples
Based on analyst estimates
- P/E forward
- 9.46x
- P/E 2026E
- 9.53x
- P/E 2027E
- 8.48x
- P/E 2028E
- 7.64x
- P/S forward
- 1.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.99x
- PEG TTM
- 0.45x
- Price / book
- 2.19x
- Price / sales
- 2.28x
- Price / cash flow
- 6.16x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 1.74x
- EV / EBITDA
- 6.05x
- EV / EBIT
- 7.25x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026